| |
| Virtual Event – R&D Leadership During the Pandemic |
| | Date: Tuesday, June 9, 2020 Time: 10:30am ET
Join this Endpoints at BIO International virtual event where R&D execs from Amgen, GSK, Janssen, Takeda, and Catalent discuss how they’ve reorganized global teams, tapped new programs as a priority to fight COVID-19, and what they plan for the future after the pandemic. |
|
|
|
|
|
|
| |
| David Reese Executive VP, Research & Development, Amgen |
|
|
|
| | |
|
|
| Hal Barron CSO & President, R&D, GlaxoSmithKline |
|
|
|
| | |
|
|
| Mathai Mammen Global Head of R&D, Janssen Pharma Company of J&J |
|
|
|
| | |
|
|
| Andrew Plump President, Research & Development, Takeda |
|
|
|
| | |
|
|
| John Chiminski Chair & CEO, Catalent |
|
|
|
|
|
|
| |
| |
| Every molecule has a challenge. We have a solution. |
| | | | or call +1 877 891 9609 to speak with one of our experts today! |
| | |
|
|
|
|
|
| |
| To unsubscribe or manage your subscriptions, please click here.
For more information call +1-866-720-3148 or in Europe 00800 88 55 6178, email us at [email protected], or visit our website www.catalent.com. And to learn more about Career opportunities across our global network, visit www.catalent.com/careers . Catalent Pharma Solutions respects your privacy. Links to third party sites are provided as a convenience only. Catalent makes no representation or warranty about the technology, security or any content available at these sites. Links are not intended to imply Catalent's affiliation or endorsement of the website, its owner(s) or the content. © 2020, Catalent Pharma Solutions, Inc. 14 Schoolhouse Road, Somerset, NJ 08873. All rights reserved. |
|
|
|
|
|
|
| |
